Publicação: Solid lipid nanoparticles optimized by 22 factorial design for skin administration: Cytotoxicity in NIH3T3 fibroblasts
dc.contributor.author | Rigon, Roberta Balansin [UNESP] | |
dc.contributor.author | Gonçalez, Maíra Lima [UNESP] | |
dc.contributor.author | Severino, Patrícia | |
dc.contributor.author | Alves, Danilo Antonini | |
dc.contributor.author | Santana, Maria H.A. | |
dc.contributor.author | Souto, Eliana B. | |
dc.contributor.author | Chorilli, Marlus [UNESP] | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.contributor.institution | Tiradentes University | |
dc.contributor.institution | Universidade Estadual de Campinas (UNICAMP) | |
dc.contributor.institution | University of Coimbra (FFUC) | |
dc.contributor.institution | University of Coimbra | |
dc.date.accessioned | 2018-12-11T17:21:58Z | |
dc.date.available | 2018-12-11T17:21:58Z | |
dc.date.issued | 2018-11-01 | |
dc.description.abstract | The present study focuses on the characterization of the cytotoxic profile on NIH3T3 mouse embryonic fibroblasts of solid lipid nanoparticles (SLN) optimized by a 22 full factorial design for skin administration. To build up the surface response charts, a design of experiments (DoE) based on 2 independent variables was used to obtain an optimized formulation. The effect of the composition of lipid and water phases on the mean particle size (z-AVE), polydispersity index (PdI) and zeta potential (ZP) was studied. The developed formulations were composed of 5.0% of lipid phase (stearic acid (SA), behenic alcohol (BA) or a blend of SA:BA (1:1)) and 4.7% of surfactants (soybean phosphatidylcholine and poloxamer 407). In vitro cytotoxicity using NIH3T3 fibroblasts was performed by MTT reduction assay. This factorial design study has proven to be a useful tool in optimizing SLN (z-AVE ∼ 200 nm), which were shown to be non-cytotoxic. The present results highlight the benefit of applying statistical designs in the preparation and optimization of SLN formulations. | en |
dc.description.affiliation | Faculty of Pharmaceutical Sciences UNESP – São Paulo State University Departamento de Fármacos e Medicamentos, Campus Araraquara | |
dc.description.affiliation | Centre of Biological Sciences and Health Tiradentes University | |
dc.description.affiliation | Laboratory of Biotechnology Institute of Biology Campinas University (UNICAMP), Campinas | |
dc.description.affiliation | Faculty of Chemical Engineering Campinas University (UNICAMP), Campinas | |
dc.description.affiliation | Department of Pharmaceutical Technology Faculty of Pharmacy University of Coimbra (FFUC), Polo das Ciências da Saúde Azinhaga de Santa Comba | |
dc.description.affiliation | REQUIMTE/LAQV Group of Pharmaceutical Technology Faculty of Pharmacy University of Coimbra | |
dc.description.affiliationUnesp | Faculty of Pharmaceutical Sciences UNESP – São Paulo State University Departamento de Fármacos e Medicamentos, Campus Araraquara | |
dc.format.extent | 501-505 | |
dc.identifier | http://dx.doi.org/10.1016/j.colsurfb.2018.07.065 | |
dc.identifier.citation | Colloids and Surfaces B: Biointerfaces, v. 171, p. 501-505. | |
dc.identifier.doi | 10.1016/j.colsurfb.2018.07.065 | |
dc.identifier.file | 2-s2.0-85050850577.pdf | |
dc.identifier.issn | 1873-4367 | |
dc.identifier.issn | 0927-7765 | |
dc.identifier.lattes | 1427125996716282 | |
dc.identifier.scopus | 2-s2.0-85050850577 | |
dc.identifier.uri | http://hdl.handle.net/11449/176661 | |
dc.language.iso | eng | |
dc.relation.ispartof | Colloids and Surfaces B: Biointerfaces | |
dc.relation.ispartofsjr | 1,071 | |
dc.rights.accessRights | Acesso aberto | pt |
dc.source | Scopus | |
dc.subject | Factorial design | |
dc.subject | Fibroblasts | |
dc.subject | MTT assay | |
dc.subject | Skin administration | |
dc.subject | Solid lipid nanoparticles | |
dc.title | Solid lipid nanoparticles optimized by 22 factorial design for skin administration: Cytotoxicity in NIH3T3 fibroblasts | en |
dc.type | Artigo | pt |
dspace.entity.type | Publication | |
relation.isDepartmentOfPublication | e214da1b-9929-4ae9-b8fd-655e9bfeda4b | |
relation.isDepartmentOfPublication.latestForDiscovery | e214da1b-9929-4ae9-b8fd-655e9bfeda4b | |
unesp.author.lattes | 1427125996716282 | |
unesp.author.orcid | 0000-0002-9737-6017 0000-0002-9737-6017[6] | |
unesp.department | Fármacos e Medicamentos - FCF | pt |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- 2-s2.0-85050850577.pdf
- Tamanho:
- 1.58 MB
- Formato:
- Adobe Portable Document Format
- Descrição: